Clorox won’t have enough disinfecting wipes until 2021, its CEO says By Reuters

Clorox won't have enough disinfecting wipes until 2021, its CEO


© Reuters. FILE PHOTO: House Committee on Education and Labor, Subcommittee on Workforce Protections Hearing “Examining the Federal Government’s Actions to Protect Workers from COVID-19” on Capitol Hill in Washington

By Richa Naidu

CHICAGO (Reuters) – Grocery shelves won’t be fully stocked with Clorox (NYSE:)’s disinfecting wipes until next year, CEO Benno Dorer told Reuters on Monday, as the world’s biggest cleaning products maker struggles with overwhelming pandemic-led demand for its top product.

Since the start of global lockdowns, makers of hygiene goods have seen a sustained boom in sales. While California-based Clorox typically holds aside excess supply for flu seasons, it says it has been unable to keep up with a six-fold increase in demand for many of its disinfectants.

The company is currently understocked across much of its portfolio, which includes Glad trash bags and Burt’s Bees lip balm. Supply for most products, like liquid bleach, will improve dramatically over the next four to six months – but not wipes, Dorer said.

Clorox products are used in Uber (NYSE:) vehicles and United Airlines planes, and are sold by major retailers like Walmart (NYSE:), Amazon (NASDAQ:) and Kroger (NYSE:).

“Disinfecting wipes, which are the hottest commodity in the business right now, will probably take longer because it’s a very complex supply chain to make them,” Dorer said. Many wipes are made from polyester spunlace, a material currently in short supply as it is also used to make personal protective equipment like masks, medical gowns and medical wipes.

“That entire supply chain is stressed. … We feel like it’s probably going to take until 2021 before we’re able to meet all the demand that we have,” Dorer said.

Dorer had said in May that Clorox expected to see shelves stocked with wipes by this summer.

Since then, Clorox has made “major” capital investments so it can ramp up output each quarter, including simplifying its disinfectant product line-up at factories that run 24/7 every day of the year. Clorox began outsourcing some manufacturing this year to 10 third-party supplies, and plans to keep looking for more.

On Monday, Clorox reported fourth-quarter sales and earnings that widely topped analysts’ expectations, driven by a 33% increase in revenue from its health and wellness business, which makes cleaning products and accounts for more than 40% of total sales.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *


About us

InvestLab is a financial services technology company focused on the global trading market. Founded in 2010 in Hong Kong, the company develops trading, market data, and social research products that enable individual investors and small to mid-size brokers to access global markets. We provide brokers and financial institutions cross border capabilities for retail investors into 43 markets globally.


CONTACT US

CALL US ANYTIME